Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351
Lists
Only you see this
Abstract
F-PI-2620 PET might be a sensitive tool to detect cortical tau deposits in patients with Aβ+ AD and Aβ+ non-AD tauopathies. Furthermore, this study showed that "off-target" binding in the basal ganglia does not affect F-PI-2620.
BibTeX
@inproceedings{oh2020clinical,
author = {Minyoung Oh and Seung Jun Oh and Sang Ju Lee and Jungsu S. Oh and Jee Hoon Roh and Sun Ju Chung and Jae‐Hong Lee and Chong Sik Lee and Jae Seung Kim},
title = {{Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351}},
booktitle = {Clinical},
year = {2020},
doi = {10.1097/rlu.0000000000003261},
}Loading related content...